SCHEMBL8523803

SCHEMBL8523803

FC(F)(CNc1ncc(Cl)c(CCNCc2n[nH]c3ccc(Cl)cc23)n1)c1ccccn1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F2 P00734 19/20 0.38
F10 P00742 3/20 0.34
GPR39 O43194 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8515805 0.92 F2 (0.40) F2F10GPR39
SCHEMBL8524852 0.91 F2 (0.37) F2GPR39
SCHEMBL8524364 0.90 F2 (0.38) F2F10
SCHEMBL8519327 0.84 PIK3CA (0.39) F2
SCHEMBL8517902 0.83 F2 (0.40) F2F10
SCHEMBL8516353 0.78 F2 (0.40) F2F10
SCHEMBL8292389 0.77 F2 (0.54) F2
SCHEMBL5772427 0.73 F2 (0.38) F2F10
SCHEMBL5774380 0.68 ALDH1A1 (0.39)
SCHEMBL8294078 0.63 F2 (0.48) F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1674464-A1 Novel thrombin inhibitors Santhera Pharmaceuticals (Schweiz) GmbH (CH) 2006-06-28 EP disclosed